Differing clinical features between Japanese and Caucasian patients with myelodysplastic syndromes: Analysis from the International Working Group for Prognosis of MDS
Yasushi Miyazaki1, Heinz Tuechler2, Guillermo Sanz3, Julie Schanz4, Guillermo Garcia-Manero5, Francesc Solé6, John M. Bennett7, David Bowen8, Pierre Fenaux9, Francois Dreyfus10, Hagop Kantarjian5, Andrea Kuendgen11, Luca Malcovati12, Mario Cazzola12, Jaroslav Cermak13, Christa Fonatsch14, Michelle M. Le Beau15, Marilyn L. Slovak16, Valeria Santini17, Michael Lübbert18
1Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan
2L. Boltzmann Institute for Leukemia Research, Vienna, Austria
3Hospital Universitario la Fe, Valencia, Spain
4University Medical Center, Clinics of Haematology and Medical Oncology, Göttingen, Germany
5The University of Texas MD Anderson Cancer Center, Houston, TX, United States
6Institut de Recerca contra la Leucèmia Josep Carreras, Barcelona, Spain
7James P. Wilmot Cancer Center, University of Rochester Medical Center, Rochester, NY, United States
8St. James's University Hospital, Leeds, United Kingdom
9Hopital Avicenne, Assistance Publique–Hopitaux de Paris (AP-HP)/University of Paris XIII, Bobigny, France
10Hopital Cochin, AP-HP, University of Paris V, Paris, France
11Heinrich-Heine University Hospital, Dusseldorf, Germany
12Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico San Matteo and University of Pavia, Pavia, Italy
13Institute of Hematology and Blood Transfusion, Praha, Czech Republic
14Medical University of Vienna, Vienna, Austria
15University of Chicago Comprehensive Cancer Research Center, Chicago, IL, United States
16Department of Pathology, University of New Mexico, Albuquerque, NM, United States
17MDS Unit, Ematologia, AOU Careggi, Università degli Studi di Firenze, Firenze, Italy
18University of Freiburg Medical Center, Faculty of Medicine, Freiburg, Germany
Tài liệu tham khảo
Thông tin
Thông tin xuất bản
Leukemia Research
Tập 73
51-57
Thông tin tác giả